ArticleAnnals of translational medicine2019

Antithrombotic therapy after coronary artery stenting in atrial fibrillation: dual therapy encompassing NOAC plus P2Y12 inhibitor is ready for prime time!

Andreas GoettePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.